Florabile: The total combined yeasts and molds count may be out of specification for the affected lots.
Brand(s)
Last updated
Summary
Product
Florabile
Issue
Health products - Product quality
What to do
Consult your health care professional if you have any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Florabile |
Florabile |
NPN 80070657 |
Tablet |
Bos taurus 100 mg, Cynara cardunculus 50mg, Magnesium oxide (MgO) 50mg, Peumus boldus 50mg, Raphanus sativus var. sativus 25mg |
800123, 800163 |
Issue
The total combined yeasts and molds count may be out of specification for the affected lots.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Natural health products
Companies
JAMP Pharma Corporation.
1310 Rue Nobel,
Boucherville, Quebec,
J4B 5H3
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type II
Identification number
RA-76623
Get notified
Receive notifications for new and updated recalls and alerts by category.